hematologyadvisor.com/news/myelofibr…

#canadianmpn #mpnsm #medtwitter #mpnresearch #mpncanada

targetedonc.com/view/individua…

#mpnresearch #medtwitter #mpncanada #canadianmpn #mpnsm

Always pleased to be asked to write a personal essay. patientpower.info/myeloprolifera… MPN Research Foundation #mpnsm MPNAdvocatesNetwork Canadian Mpn Research Foundation Global MPN Scientific Foundation

💡 Ready to shape the future of #hematology ? 🩸 Last chance to apply to conduct a Scientific Workshop at #ASH2024 ! Applications close on May 13.

Apply Now: ow.ly/jkON50QIOQJ

#MedTwitter

Our recent #ClinicalTrialClub ended with a dynamic Q&A session, where Angela Fleischman and J.J. Kiladjian answered questions from the audience on treatment sequencing for anemic #myelofibrosis .

Catch up here 👉 loom.ly/8heEYEk

#MPN #MPN sm #MedicalEducation Angela Fleischman

Could fedratinib be the best available treatment in patients with #MF previously treated with ruxolitinib?

Read our article summarizing the latest data from the phase III FREEDOM2 trial 👉 loom.ly/bVTQRKA

#mpnsm #MedicalEducation

targetedonc.com/view/masarova-…

#medtwitter #mpnresearch #mpncanada #canadianmpn #mpnsm

onclive.com/view/expansion…

#medtwitter #mpnsm #mpnresearch #mpncanada #canadianmpn

Discover the latest molecular breakthroughs paving the way for precision medicine and transformative treatments.
pvreporter.com/precision-medi…

#mpnsm #pvreporter #research

Access free #ASH23 DEI content 💻 Topics include:

Outcome Disparities in Hematologic Diseases: The Importance of Social Determinants in Health

How to Support LGBTQIA Patients, Trainees, and Colleagues: A Whole Person Perspective

And more: ow.ly/1vrW50RiwcT #NMHM24

“I would like to see the federal and provincial governments work together to create change” says Amy, a #RareDisease advocate with Thalassemia Major.

Watch her interview 👉 t.ly/0RylC
#FightForOurLives #CdnPoli #CdnHealth

How do treosulfan-based conditioning regimens compare to busulfan-based conditioning regimens in patients with MF who will undergo allo-HSCT? Read more here loom.ly/RvL6lKI
#mpnsm #MedicalEducation

ajmc.com/view/new-data-…

#mpnsm #mpncanada #mpnresearch #canadianmpn #medtwitter

If a matched donor is not available for an allo-HSCT in patients with #MF , what is the next best alternative transplant option? Find out more here: loom.ly/-nv40TI
#mpnsm #MedicalEducation

How can Canada better support patients with #RareDiseases ?

Alanna (Where Are My Pillows), a rare disease advocate with autoimmune encephalitis, shares her thoughts 👉 t.ly/tu8SJ
#FightForOurLives #CdnHealth #CdnPoli

'Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms.'

nature.com/articles/s4140…

#mpnresearch #mpncanada #canadianmpn #mpnsm #medtwitter

We’re excited to launch a new interview series featuring #RareDisease patients. Their powerful stories shed light on the urgent need for improved rare disease care in

Canada. Stay tuned and join the convo ➡️ fightforourlives.ca

#FightForOurLives #CdnHealth #CdnPoli

Phlebotomies help reduce hematocrit (HCT) to <45% in #polycythemiavera (PV), but too frequent phlebotomies may exacerbate disease-related iron deficiency in patients.

Learn more about PV on our website: bit.ly/4aOg5B3

Proud to introduce this new WebMD series. A patient guide can make the MF experience easier to navigate, and anxiety of ET/PV progression. Questions for Your Doctor About Myelofibrosis MPN Research Foundation Canadian Mpn Research Foundation Silver MPN Center MPNAdvocatesNetwork PV Reporter #mpnsm webmd.com/apptprep/your-…

'Raajit K. Rampal, MD, PhD, discussed the correlation between spleen volume responses and survival outcomes for patients with myelofibrosis'.

targetedonc.com/view/connectin…

#medtwitter #mpnsm #mpncanada #mpnresearch